{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:25:12Z","timestamp":1777368312785,"version":"3.51.4"},"reference-count":179,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/md.0000000000000971","type":"journal-article","created":{"date-parts":[[2015,8,6]],"date-time":"2015-08-06T20:34:58Z","timestamp":1438893298000},"page":"e0971","source":"Crossref","is-referenced-by-count":7,"title":["Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases"],"prefix":"10.1097","volume":"94","author":[{"given":"Rikitha","family":"Menezes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Pantelyat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izlem","family":"Izbudak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210309","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1212\/WNL.44.10.1865","article-title":"Parkinsons disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990.","volume":"44","author":"Gorell","year":"1994","journal-title":"Neurology"},{"key":"R2-3-20210309","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0025-6196(11)62259-3","article-title":"Medical services utilization and prognosis in Parkinson disease: a population-based study.","volume":"77","author":"Parashos","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"R3-3-20210309","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1212\/WNL.55.3.388","article-title":"Quality of life in ALS depends on factors other than strength and physical function.","volume":"55","author":"Simmons","year":"2000","journal-title":"Neurology"},{"key":"R4-3-20210309","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fneur.2012.00150","article-title":"Antiphospholipid-related chorea.","volume":"3","author":"Peluso","year":"2012","journal-title":"Front Neurol"},{"key":"R5-3-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","article-title":"Description of Parkinsons disease as a clinical syndrome.","volume":"991","author":"Fahn","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"R6-3-20210309","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ncl.2014.09.012","article-title":"Atypical Parkinsonism: diagnosis and treatment.","volume":"33","author":"Stamelou","year":"2015","journal-title":"Neurol Clin"},{"key":"R7-3-20210309","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11940-014-0319-0","article-title":"Treatment of frontotemporal dementia.","volume":"16","author":"Tsai","year":"2014","journal-title":"Curr Treat Options Neurol"},{"key":"R11-3-20210309","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(05)70285-4","article-title":"The diagnosis of Parkinsons disease.","volume":"5","author":"Tolosa","year":"2006","journal-title":"Lancet Neurol"},{"key":"R12-3-20210309","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/practneurol-2011-000132","article-title":"Improving the diagnostic accuracy in parkinsonism: a three-pronged approach.","volume":"12","author":"Aerts","year":"2012","journal-title":"Pract Neurol"},{"key":"R13-3-20210309","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.revmed.2012.09.017","article-title":"Parkinsonian disorders: from clinical manifestations to diagnostic classification.","volume":"34","author":"Bourdain","year":"2013","journal-title":"Rev Med Interne"},{"key":"R14-3-20210309","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1474-4422(03)00662-8","article-title":"Multiple system atrophy.","volume":"3","author":"Wenning","year":"2004","journal-title":"Lancet Neurol"},{"key":"R15-3-20210309","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy.","volume":"163","author":"Gilman","year":"1999","journal-title":"J Neurol Sci"},{"key":"R16-3-20210309","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mds.25847","article-title":"Multiple system atrophy of the cerebellar type: clinical state of the art.","volume":"29","author":"Lin","year":"2014","journal-title":"Mov Disord"},{"key":"R17-3-20210309","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMra1311488","article-title":"Multiple-system atrophy.","volume":"372","author":"Fanciulli","year":"2015","journal-title":"N Engl J Med"},{"key":"R18-3-20210309","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-0034-1381737","article-title":"Multiple system atrophy.","volume":"34","author":"Peeraully","year":"2014","journal-title":"Semin Neurol"},{"key":"R19-3-20210309","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/jnnp.64.2.184","article-title":"Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination.","volume":"64","author":"Wenning","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R20-3-20210309","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1212\/CPJ.0000000000000026","article-title":"Corticobasal syndrome: five new things.","volume":"4","author":"Chahine","year":"2014","journal-title":"Neurol Clin Pract"},{"key":"R21-3-20210309","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-0034-1381736","article-title":"Progressive supranuclear palsy.","volume":"34","author":"Golbe","year":"2014","journal-title":"Semin Neurol"},{"key":"R22-3-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"R23-3-20210309","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/jnnp.58.2.167","article-title":"Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.","volume":"58","author":"Collins","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R25-3-20210309","first-page":"416","article-title":"The Lund and Manchester Groups.","volume":"57","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R26-3-20210309","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ncl.2007.03.005","article-title":"Frontotemporal lobar degeneration.","volume":"25","author":"Josephs","year":"2007","journal-title":"Neurol Clin"},{"key":"R27-3-20210309","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ana.20700","article-title":"Clinical and pathological characterization of progressive aphasia.","volume":"59","author":"Knibb","year":"2006","journal-title":"Ann Neurol"},{"key":"R28-3-20210309","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.20203","article-title":"Clinicopathological correlates in frontotemporal dementia.","volume":"56","author":"Hodges","year":"2004","journal-title":"Ann Neurol"},{"key":"R29-3-20210309","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/NRL.0b013e3181ebe59f","article-title":"Peripheral nervous system manifestations of Sjogren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies.","volume":"16","author":"Birnbaum","year":"2010","journal-title":"Neurologist"},{"key":"R30-3-20210309","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000073055","article-title":"Neurophysiological diagnosis of acquired sensory ganglionopathies.","volume":"50","author":"Lauria","year":"2003","journal-title":"Eur Neurol"},{"issue":"Pt 11","key":"R31-3-20210309","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh605","article-title":"The wide spectrum of clinical manifestations in Sjogrens syndrome-associated neuropathy.","volume":"128","author":"Mori","year":"2005","journal-title":"Brain"},{"key":"R32-3-20210309","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.410270313","article-title":"Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogrens syndrome.","volume":"27","author":"Griffin","year":"1990","journal-title":"Ann Neurol"},{"key":"R33-3-20210309","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.wnl.0000176034.38198.f9","article-title":"Painful small-fiber neuropathy in Sjogren syndrome.","volume":"65","author":"Chai","year":"2005","journal-title":"Neurology"},{"key":"R34-3-20210309","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/art.38302","article-title":"Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period.","volume":"66","author":"Oomatia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R35-3-20210309","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogrens syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R36-3-20210309","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","article-title":"Neuronal autoantigenspathogenesis, associated disorders and antibody testing.","volume":"8","author":"Lancaster","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"R37-3-20210309","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1155\/2008\/824631","article-title":"Neurological disorders in adult celiac disease.","volume":"22","author":"Freeman","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"R38-3-20210309","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1212\/WNL.0b013e3181f25ee0","article-title":"Sensory ganglionopathy due to gluten sensitivity.","volume":"75","author":"Hadjivassiliou","year":"2010","journal-title":"Neurology"},{"key":"R39-3-20210309","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/jnnp.2005.084533","article-title":"Intravenous immunoglobulin treatment in painful sensory neuropathy without sensory ataxia associated with Sjogrens syndrome.","volume":"77","author":"Kizawa","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R40-3-20210309","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jnnp.60.6.699","article-title":"Intravenous immunoglobulin therapy in sensory neuropathy associated with Sjogrens syndrome.","volume":"60","author":"Molina","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R41-3-20210309","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/s10165-009-0180-2","article-title":"Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogrens syndrome.","volume":"19","author":"Wakasugi","year":"2009","journal-title":"Mod Rheumatol"},{"key":"R42-3-20210309","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/jnnp.2010.222109","article-title":"Peripheral neuropathies in Sjogren syndrome: a new reappraisal.","volume":"82","author":"Pavlakis","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R44-3-20210309","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/WNL.58.11.1615","article-title":"The prevalence of frontotemporal dementia.","volume":"58","author":"Ratnavalli","year":"2002","journal-title":"Neurology"},{"key":"R45-3-20210309","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.40.8.1203","article-title":"Cortical-basal ganglionic degeneration.","volume":"40","author":"Riley","year":"1990","journal-title":"Neurology"},{"key":"R46-3-20210309","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(99)04137-9","article-title":"Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study.","volume":"354","author":"Schrag","year":"1999","journal-title":"Lancet"},{"key":"R47-3-20210309","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/S1041610209008862","article-title":"Pattern of behavioral disturbances in corticobasal degeneration syndrome and progressive supranuclear palsy.","volume":"21","author":"Borroni","year":"2009","journal-title":"Int Psychogeriatr"},{"key":"R48-3-20210309","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/nan.12037","article-title":"Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.","volume":"40","author":"Ling","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R49-3-20210309","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14802\/jmd.12010","article-title":"Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.","volume":"5","author":"Lee","year":"2012","journal-title":"J Mov Disord"},{"key":"R50-3-20210309","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/0961203313491023","article-title":"Rituximab therapy for recurrent thromboembolic disease in antiphospholipid syndrome.","volume":"22","author":"Bakshi","year":"2013","journal-title":"Lupus"},{"key":"R51-3-20210309","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.autrev.2012.12.006","article-title":"Antiphospholipid syndrome: from pathogenesis to novel immunomodulatory therapies.","volume":"12","author":"Comarmond","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R53-3-20210309","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"R54-3-20210309","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.59.5.764","article-title":"PQ type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer.","volume":"59","author":"Graus","year":"2002","journal-title":"Neurology"},{"key":"R55-3-20210309","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1097-4598(199901)22:1<119::AID-MUS19>3.0.CO;2-5","article-title":"PQ-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system.","volume":"22","author":"Voltz","year":"1999","journal-title":"Muscle Nerve"},{"key":"R56-3-20210309","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(81)90474-8","article-title":"Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome.","volume":"2","author":"Lang","year":"1981","journal-title":"Lancet"},{"key":"R57-3-20210309","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 Classification Criteria for Systemic Sclerosis: An American College of RheumatologyEuropean League Against Rheumatism Collaborative Initiative.","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R58-3-20210309","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2249.2004.02497.x","article-title":"Antiphospholipid syndrome: multiple mechanisms.","volume":"136","author":"Mackworth-Young","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R59-3-20210309","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1006\/jaut.1998.0214","article-title":"Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells.","volume":"11","author":"Caronti","year":"1998","journal-title":"J Autoimmun"},{"key":"R60-3-20210309","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1191\/096120399678847524","article-title":"Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes.","volume":"8","author":"Chapman","year":"1999","journal-title":"Lupus"},{"key":"R61-3-20210309","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus.","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"R62-3-20210309","first-page":"725","article-title":"Parkinson disease of juvenile onset with systemic lupus erythematosus in a pre-symptomatic stage.","volume":"29","author":"Chacon","year":"1999","journal-title":"Rev Neurol"},{"key":"R63-3-20210309","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1469-8749.2011.03922.x","article-title":"Antibody binding to neuronal surface in movement disorders associated with lupus and antiphospholipid antibodies.","volume":"53","author":"Dale","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"R64-3-20210309","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/mds.10288","article-title":"Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature.","volume":"17","author":"Garcia-Moreno","year":"2002","journal-title":"Mov Disord"},{"key":"R65-3-20210309","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0961203307081421","article-title":"Unusual neurologic manifestations (I): Parkinsonism in juvenile SLE.","volume":"16","author":"Khubchandani","year":"2007","journal-title":"Lupus"},{"key":"R66-3-20210309","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0887-8994(97)00229-4","article-title":"Parkinsonian syndrome complicating systemic lupus erythematosus.","volume":"18","author":"Shahar","year":"1998","journal-title":"Pediatr Neurol"},{"key":"R67-3-20210309","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1191\/096120300678828578","article-title":"Parkinsonism as unusual neurological complication in childhood systemic lupus erythematosus.","volume":"9","author":"Kwong","year":"2000","journal-title":"Lupus"},{"key":"R68-3-20210309","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/art.1780241109","article-title":"Central nervous-system involvement in childhood systemic lupus-erythematosus.","volume":"24","author":"Yancey","year":"1981","journal-title":"Arthritis Rheum"},{"key":"R69-3-20210309","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000130347.69790.E8","article-title":"Acute cerebellar ataxia due to Sjogren syndrome.","volume":"62","author":"Wong","year":"2004","journal-title":"Neurology"},{"key":"R70-3-20210309","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/088307380101600911","article-title":"Central nervous system Sjogrens syndrome in a child: case report and review of the literature.","volume":"16","author":"Gottfried","year":"2001","journal-title":"J Child Neurol"},{"key":"R72-3-20210309","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00296-008-0778-2","article-title":"Antiphospholipid antibody, head-shaking and ataxia: an evidence of non-vascular neurotoxicity and successful treatment by plasmapheresis.","volume":"29","author":"Chen","year":"2009","journal-title":"Rheumatol Int"},{"key":"R73-3-20210309","first-page":"391","article-title":"Symptomatic hemiparkinsonism with abnormal SPECT in a patient with systemic lupus erythematosus (SLE).","volume":"17","author":"Morales-Buenrostro","year":"2002","journal-title":"Neurologia"},{"key":"R75-3-20210309","first-page":"721","article-title":"Cuatro casos clinicos de lupus eritematoso agudo.","volume":"2","year":"1930","journal-title":"Sem Med (B Air)"},{"key":"R76-3-20210309","first-page":"180","article-title":"Two cases of posthemiplegic dystonia and contralateral striatal low density area on CT caused by inflammatory vasculitis.","volume":"26","author":"Anegawa","year":"1986","journal-title":"Rinsho Shinkeigaku"},{"key":"R77-3-20210309","first-page":"225","article-title":"Neuro-Behcets syndrome with palatal myoclonus (authors transl).","volume":"19","author":"Nakamura","year":"1979","journal-title":"Rinsho Shinkeigaku"},{"key":"R78-3-20210309","first-page":"743","article-title":"Case of systemic lupus erythematosus (SLE) with giant cell arteritis of the brain causing akinetic mutism and myclonus.","volume":"15","author":"Noto","year":"1975","journal-title":"Rinsho Shinkeigaku"},{"key":"R79-3-20210309","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1055\/s-0028-1106544","article-title":"Early CNS manifestations in lupus erythematosus (authors transl).","volume":"100","author":"Krankenhagen","year":"1975","journal-title":"Dtsch Med Wochenschr"},{"key":"R80-3-20210309","first-page":"233","article-title":"A case of neuro-Behcets disease presenting as chronic progressive cerebellar ataxia.","volume":"40","author":"Yamasaki","year":"2000","journal-title":"Rinsho Shinkeigaku"},{"key":"R81-3-20210309","first-page":"946","article-title":"Primary Sjogrens syndrome presenting with choreo-athetosis.","volume":"42","author":"Nakazato","year":"2002","journal-title":"Rinsho Shinkeigaku"},{"key":"R82-3-20210309","first-page":"921","article-title":"A case of neuro-Behcets disease with HLA B54 and predominant cerebral white matter lesions.","volume":"40","author":"Iwatsuki","year":"2000","journal-title":"Rinsho Shinkeigaku"},{"key":"R83-3-20210309","first-page":"45","article-title":"A case of neuro-Behcets disease presenting with chorea.","volume":"41","author":"Kimura","year":"2001","journal-title":"Rinsho Shinkeigaku"},{"key":"R84-3-20210309","first-page":"165","article-title":"Severe dysphagia in Huntingtons chorea with associated scleroderma.","volume":"120","author":"Gimenez-Roldan","year":"1971","journal-title":"Rev Clin Esp"},{"key":"R85-3-20210309","first-page":"304","article-title":"Chorea as the presenting form of progressive systemic sclerosis.","volume":"15","author":"Seijo Martinez","year":"2000","journal-title":"Neurologia"},{"key":"R86-3-20210309","first-page":"318","article-title":"Clinicopathologic conference: psychotic episodes, meningitis and chest pain.","volume":"35","author":"Willoughby","year":"1964","journal-title":"Postgrad Med"},{"key":"R87-3-20210309","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-196807000-00002","article-title":"The neurological manifestations of systemic lupus erythematosus.","volume":"47","author":"Johnson","year":"1968","journal-title":"Medicine (Baltimore)"},{"key":"R88-3-20210309","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0002-9343(63)90078-0","article-title":"Neurologic aspects of Behcets disease. Case report and review of the literature.","volume":"34","author":"Schotland","year":"1963","journal-title":"Am J Med"},{"key":"R89-3-20210309","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/rhe1.1966.12.issue-1-4.33","article-title":"Rheumatoid arthritis with chorea. A case report.","volume":"12","author":"Diederichsen","year":"1966","journal-title":"Acta Rheumatol Scand"},{"key":"R90-3-20210309","first-page":"137","article-title":"Acute rheumatoid arthritis and Sydenhams chorea.","volume":"12","author":"Zivic","year":"1965","journal-title":"Reumatizam"},{"key":"R91-3-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneurpsyc.1956.02330190009001","article-title":"The neurological complications of Behcets syndrome.","volume":"75","author":"Pallis","year":"1956","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"R92-3-20210309","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/rheumatology\/38.7.627","article-title":"Extrapyramidal type rigidity in rheumatoid arthritis.","volume":"38","author":"Ertan","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"R93-3-20210309","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1331.2006.01613.x","article-title":"Neuro-Behcets disease in Caucasians: a study of 22 patients.","volume":"14","author":"Joseph","year":"2007","journal-title":"Eur J Neurol"},{"key":"R94-3-20210309","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.neurol.2012.03.010","article-title":"Parkinsonism as first manifestation of lupus.","volume":"168","author":"Lachhab","year":"2012","journal-title":"Rev Neurol (Paris)"},{"key":"R95-3-20210309","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10072-014-1660-5","article-title":"Parkinsons disease associated with myasthenia gravis and rheumatoid arthritis.","volume":"35","author":"Zis","year":"2014","journal-title":"Neurol Sci"},{"key":"R96-3-20210309","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/096120339300200314","article-title":"Parkinson-like symptoms as a manifestation of systemic lupus erythematosus.","volume":"2","author":"Miyoshi","year":"1993","journal-title":"Lupus"},{"key":"R98-3-20210309","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1468-1331.1998.530309.x","article-title":"Systemic lupus erythematosus presenting with steroid-responsive parkinsonism and post-hemiplegic dystonia.","volume":"5","author":"Lim","year":"1998","journal-title":"Eur J Neurol"},{"key":"R99-3-20210309","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/096120339700600710","article-title":"Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms.","volume":"6","author":"Osawa","year":"1997","journal-title":"Lupus"},{"key":"R100-3-20210309","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-510X(01)00604-9","article-title":"Reversible parkinsonism in systemic lupus erythematosus.","volume":"193","author":"Tan","year":"2001","journal-title":"J Neurol Sci"},{"key":"R101-3-20210309","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/mds.10029","article-title":"Reversible parkinsonian syndrome in systemic and brain vasculitis.","volume":"17","author":"Fabiani","year":"2002","journal-title":"Mov Disord"},{"key":"R102-3-20210309","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1212\/01.WNL.0000130255.16674.9B","article-title":"Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism.","volume":"63","author":"Lee","year":"2004","journal-title":"Neurology"},{"key":"R103-3-20210309","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1212\/01.wnl.0000267320.48939.d0","article-title":"CNS lupus: a study of 41 patients.","volume":"69","author":"Joseph","year":"2007","journal-title":"Neurology"},{"key":"R104-3-20210309","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.parkreldis.2007.08.001","article-title":"Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus.","volume":"14","author":"Orta Daniel","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"key":"R105-3-20210309","first-page":"103","article-title":"Parkinsonian syndrome as a complication of systemic lupus erythematosus. Report of a case and review of the literature.","volume":"60","author":"Chemaly","year":"2012","journal-title":"J Med Liban"},{"key":"R106-3-20210309","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.berh.2005.04.003","article-title":"Management of neuropsychiatric lupus.","volume":"19","author":"Hanly","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R107-3-20210309","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mds.22937","article-title":"Differentiating vascular parkinsonism from idiopathic Parkinsons disease: a systematic review.","volume":"25","author":"Kalra","year":"2010","journal-title":"Mov Disord"},{"key":"R109-3-20210309","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0303-8467(93)90009-6","article-title":"Hemiparkinsonism in a patient with primary Sjogrens syndrome. A case report and a review of the literature.","volume":"95","author":"Visser","year":"1993","journal-title":"Clin Neurol Neurosurg"},{"key":"R110-3-20210309","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0303-8467(94)90124-4","article-title":"Corticosteroid-responsive parkinsonism associated with primary Sjogrens syndrome.","volume":"96","author":"Nishimura","year":"1994","journal-title":"Clin Neurol Neurosurg"},{"key":"R111-3-20210309","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.870120124","article-title":"Primary Sjogrens syndrome presenting as progressive parkinsonian syndrome.","volume":"12","author":"Creange","year":"1997","journal-title":"Mov Disord"},{"key":"R112-3-20210309","first-page":"57","article-title":"A case of Sjogrens syndrome with a high titer of anticardiolipin antibody that developed as parkinsonism.","volume":"37","author":"Mochizuki","year":"1997","journal-title":"Rinsho Shinkeigaku"},{"key":"R113-3-20210309","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/1531-8257(199903)14:2<262::AID-MDS1011>3.0.CO;2-6","article-title":"Parkinsonism associated with Sjogrens syndrome: three cases and a review of the literature.","volume":"14","author":"Walker","year":"1999","journal-title":"Mov Disord"},{"key":"R114-3-20210309","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10067-006-0398-8","article-title":"Anti-beta2-glycoprotein I in Sjogrens syndrome is associated with parkinsonism.","volume":"26","author":"Hassin-Baer","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R115-3-20210309","first-page":"29","article-title":"Neurological involvement in Primary Sjogren syndrome.","volume":"38","author":"Teixeira","year":"2013","journal-title":"Acta Reumatol Port"},{"key":"R116-3-20210309","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1017\/S0317167100033552","article-title":"Parkinsonian syndrome as a neurological manifestation of Behcets disease.","volume":"25","author":"Bogdanova","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"R117-3-20210309","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1474-4422(09)70015-8","article-title":"Neuro-Behcets disease: epidemiology, clinical characteristics, and management.","volume":"8","author":"Al-Araji","year":"2009","journal-title":"Lancet Neurol"},{"key":"R118-3-20210309","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jns.2007.10.003","article-title":"Parkinsonism in a patient with antiphospholipid syndromecase report and literature review.","volume":"267","author":"Huang","year":"2008","journal-title":"J Neurol Sci"},{"key":"R119-3-20210309","first-page":"623","article-title":"Antiphospholipid syndrome and parkinsonism.","volume":"16","author":"Milanov","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"R120-3-20210309","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1353-8020(00)00025-0","article-title":"Antiphospholipid syndrome and dystonia-parkinsonism. A case report.","volume":"7","author":"Milanov","year":"2001","journal-title":"Parkinsonism Relat Disord"},{"key":"R121-3-20210309","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/rheumatology\/keg160","article-title":"Severe Parkinsons disease in rheumatoid arthritis patient treated with infliximab.","volume":"42","author":"Hrycaj","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"R122-3-20210309","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/RHU.0B013E318178825f","article-title":"Rheumatoid arthritis accompanied by parkinson disease.","volume":"14","author":"Kogure","year":"2008","journal-title":"J Clin Rheumatol"},{"key":"R123-3-20210309","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/1531-8257(199905)14:3<530::AID-MDS1030>3.0.CO;2-8","article-title":"Primary antiphospholipid syndrome presenting as a corticobasal degeneration syndrome.","volume":"14","author":"Morris","year":"1999","journal-title":"Mov Disord"},{"key":"R124-3-20210309","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mds.20842","article-title":"Atypical movement disorders in antiphospholipid syndrome.","volume":"21","author":"Martino","year":"2006","journal-title":"Mov Disord"},{"key":"R125-3-20210309","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/WNL.0000000000000152","article-title":"Corticobasal syndrome associated with antiphospholipid syndrome without cerebral infarction.","volume":"82","author":"Lee","year":"2014","journal-title":"Neurology"},{"key":"R126-3-20210309","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1191\/0961203303lu242CR","article-title":"Primary antiphospholipid antibody syndrome masquerading as progressive supranuclear palsy.","volume":"12","author":"Reitblat","year":"2003","journal-title":"Lupus"},{"key":"R127-3-20210309","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/096120339300200212","article-title":"Amyotrophic lateral sclerosis in a patient with systemic lupus erythematosus.","volume":"2","author":"Forns","year":"1993","journal-title":"Lupus"},{"key":"R128-3-20210309","first-page":"633","article-title":"Neuropsychiatric systemic lupus erythematosus presenting as amyotrophic lateral sclerosis.","volume":"29","author":"Maldonado","year":"2002","journal-title":"J Rheumatol"},{"key":"R129-3-20210309","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10067-011-1923-y","article-title":"Association of amyotrophic lateral sclerosis and Behcets disease: is there a relationship A multi-national case series.","volume":"31","author":"Mrabet","year":"2012","journal-title":"Clin Rheumatol"},{"key":"R130-3-20210309","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00296-010-1760-3","article-title":"Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature.","volume":"31","author":"Padovan","year":"2011","journal-title":"Rheumatol Int"},{"key":"R131-3-20210309","first-page":"70","article-title":"Rheumatoid arthritis and motor neuron diseasean association R","volume":"28","author":"Schady","year":"1989","journal-title":"heumatology"},{"key":"R132-3-20210309","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/rheumatology\/kel232","article-title":"Is TNFalpha really a good therapeutic target in motoneuronal degeneration A case of amyotrophic lateral sclerosis in a patient with RA receiving infliximab.","volume":"45","author":"Dziadzio","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R133-3-20210309","first-page":"213","article-title":"Diagnosis of amyotrophic lateral sclerosis in a patient treated with TNFalpha blockers for ankylosing spondylitis: fortuitus association or new side effect of TNFalpha blockers Joint Bone S","volume":"76","author":"Loustau","year":"2009","journal-title":"pine"},{"key":"R134-3-20210309","first-page":"711","article-title":"ALS: disease or syndrome J Neurol Neurosurg P","volume":"82","author":"van den Berg","year":"2011","journal-title":"sychiatry"},{"key":"R135-3-20210309","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","article-title":"Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study.","volume":"82","author":"Chio","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R136-3-20210309","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0140-6736(94)91864-3","article-title":"Antineuronal antibody in Sjogrens syndrome masquerading as paraneoplastic cerebellar degeneration.","volume":"343","author":"Terao","year":"1994","journal-title":"Lancet"},{"key":"R137-3-20210309","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-510X(02)00034-5","article-title":"Motor weakness and cerebellar ataxia in Sjogren syndromeidentification of antineuronal antibody: a case report.","volume":"197","author":"Owada","year":"2002","journal-title":"J Neurol Sci"},{"key":"R138-3-20210309","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3988\/jcn.2012.8.2.155","article-title":"Cerebellar degeneration associated with Sjogrens syndrome.","volume":"8","author":"Kim","year":"2012","journal-title":"J Clin Neurol"},{"key":"R139-3-20210309","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00415-007-0596-6","article-title":"Asymmetric cerebellar ataxia and limbic encephalitis as a presenting feature of primary Sjogrens syndrome.","volume":"254","author":"Collison","year":"2007","journal-title":"J Neurol"},{"key":"R140-3-20210309","first-page":"81","article-title":"Sjogrens syndrome with acute cerebellar ataxia and massive lymphadenopathy: a case report.","volume":"22","author":"Chen","year":"2013","journal-title":"Acta Neurol Taiwan"},{"key":"R141-3-20210309","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0140-6736(93)91524-P","article-title":"Purkinje cell antibody in lupus ataxia.","volume":"342","author":"Shimomura","year":"1993","journal-title":"Lancet"},{"key":"R142-3-20210309","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0303-8467(96)00013-3","article-title":"Subacute pancerebellar syndrome associated with systemic lupus erythematosus.","volume":"98","author":"Manto","year":"1996","journal-title":"Clin Neurol Neurosurg"},{"key":"R143-3-20210309","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/096120339500400513","article-title":"Cerebellar atrophy in systemic lupus erythematosus.","volume":"4","author":"al-Arfaj HF, Naddaf","year":"1995","journal-title":"Lupus"},{"key":"R144-3-20210309","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/0961203311418270","article-title":"Subacute cerebellar ataxia and atrophy developed in a young woman with systemic lupus erythematosus whose cerebrospinal fluid was positive for antineuronal cell antibody.","volume":"21","author":"Iwasaki","year":"2012","journal-title":"Lupus"},{"key":"R145-3-20210309","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1177\/0961203311403346","article-title":"Acute cerebellar ataxia in lupus.","volume":"20","author":"Chattopadhyay","year":"2011","journal-title":"Lupus"},{"key":"R146-3-20210309","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0404.1992.tb05111.x","article-title":"Magnetic resonance imaging findings in lupus ataxia.","volume":"86","author":"Lancman","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"R147-3-20210309","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1177\/0961203308093071","article-title":"Cerebellar ataxia in systemic lupus erythematosus.","volume":"17","author":"Appenzeller","year":"2008","journal-title":"Lupus"},{"key":"R148-3-20210309","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00296-006-0171-y","article-title":"A possible variant of neuro-Behcet disease presenting chronic progressive ataxia without mucocutaneo-ocular symptoms.","volume":"27","author":"Hirose","year":"2006","journal-title":"Rheumatol Int"},{"key":"R149-3-20210309","first-page":"307","article-title":"Ataxia and cerebellar atrophya novel manifestation of neuro-Behcet disease Mov D","volume":"23","author":"Gardner","year":"2008","journal-title":"isord"},{"key":"R150-3-20210309","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archinte.1985.00360050219043","article-title":"Palatal myoclonus in Behcets disease.","volume":"145","author":"Shuttleworth","year":"1985","journal-title":"Arch Intern Med"},{"key":"R151-3-20210309","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0022-510X(91)90111-J","article-title":"Palatal myoclonus following Behcets disease ameliorated by ceruletide, a potent analogue of CCK octapeptide.","volume":"105","author":"Iwasaki","year":"1991","journal-title":"J Neurol Sci"},{"key":"R152-3-20210309","doi-asserted-by":"crossref","first-page":"336","DOI":"10.2169\/internalmedicine.32.336","article-title":"Sleep apnea and palatal myoclonus in a patient with neuro-Behcet syndrome.","volume":"32","author":"Sakurai","year":"1993","journal-title":"Intern Med"},{"key":"R153-3-20210309","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/mds.23214","article-title":"Lingual myoclonus secondary to bilateral cortical strokes in a probable case of antiphospholipid syndrome.","volume":"25","author":"Jagota","year":"2010","journal-title":"Mov Disord"},{"key":"R154-3-20210309","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1056\/NEJMicm0806049","article-title":"Images in clinical medicine. Essential palatal myoclonus.","volume":"362","author":"Scozzafava","year":"2010","journal-title":"N Engl J Med"},{"key":"R155-3-20210309","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/mds.22456","article-title":"Paroxysmal dystonia associated to primary Sjogrens syndrome.","volume":"24","author":"Alonso-Navarro","year":"2009","journal-title":"Mov Disord"},{"key":"R156-3-20210309","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8257(199909)14:5<860::AID-MDS1024>3.0.CO;2-8","article-title":"Painful tonicdystonic spasms in Sjogrens syndrome.","volume":"14","author":"Jabbari","year":"1999","journal-title":"Mov Disord"},{"key":"R157-3-20210309","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s10067-006-0519-4","article-title":"Orofacial dystonia related to Sjogrens syndrome.","volume":"26","author":"Papageorgiou","year":"2007","journal-title":"Clin Rheumatol"},{"key":"R158-3-20210309","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1531-8257(199903)14:2<374::AID-MDS1032>3.0.CO;2-W","article-title":"Dystonia; a central nervous system presentation of Sjogrens syndrome.","volume":"14","author":"van den Berg","year":"1999","journal-title":"Mov Disord"},{"key":"R159-3-20210309","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/jnnp.51.1.151","article-title":"Late onset posthemiplegic dystonia in systemic lupus erythematosus.","volume":"51","author":"Daras","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R160-3-20210309","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/mds.870040410","article-title":"Torticollis and blepharospasm in systemic lupus erythematosus.","volume":"4","author":"Rajagopalan","year":"1989","journal-title":"Mov Disord"},{"key":"R161-3-20210309","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000047979","article-title":"Paroxysmal focal dystonia in neuro-Behcet by a small ipsilateral thalamic lesion.","volume":"47","author":"Guak","year":"2002","journal-title":"Eur Neurol"},{"key":"R162-3-20210309","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1531-8257(199901)14:1<177::AID-MDS1037>3.0.CO;2-N","article-title":"Paroxysmal dystonia in Behcets disease.","volume":"14","author":"Pellecchia","year":"1999","journal-title":"Mov Disord"},{"key":"R163-3-20210309","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/1531-8257(200007)15:4<741::AID-MDS1025>3.0.CO;2-5","article-title":"Chorea and jaw-opening dystonia as a manifestation of NeuroBehcets syndrome.","volume":"15","author":"Revilla","year":"2000","journal-title":"Mov Disord"},{"key":"R164-3-20210309","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/rheumatology\/30.6.478","article-title":"Psoriatic spondylitis presenting as chronic torticollis.","volume":"30","author":"Witham","year":"1991","journal-title":"Br J Rheumatol"},{"key":"R165-3-20210309","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00702-013-1023-z","article-title":"Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome.","volume":"120","author":"Baizabal-Carvallo","year":"2013","journal-title":"J Neural Transm"},{"key":"R166-3-20210309","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature.","volume":"76","author":"Cervera","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"R167-3-20210309","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.parkreldis.2008.06.007","article-title":"Bilateral basal ganglia lesions of primary Sjogren syndrome presenting with generalized chorea.","volume":"15","author":"Min","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"R168-3-20210309","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.parkreldis.2004.10.006","article-title":"Primary Sjogrens syndrome presenting as a generalized chorea.","volume":"11","author":"Venegas Fanchke","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"key":"R169-3-20210309","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10067-004-0897-4","article-title":"Neuro-Behcets disease with chorea after remission of intestinal Behcets disease.","volume":"23","author":"Kuriwaka","year":"2004","journal-title":"Clin Rheumatol"},{"key":"R170-3-20210309","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00313774","article-title":"Chorea in Behcets syndrome.","volume":"227","author":"Bussone","year":"1982","journal-title":"J Neurol"},{"key":"R171-3-20210309","first-page":"263","article-title":"Choreaa presenting feature of giant cell arteritis.","volume":"46","author":"Haq","year":"1996","journal-title":"J Pak Med Assoc"},{"key":"R172-3-20210309","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1212\/WNL.38.3.352","article-title":"Neurologic disease in biopsy-proven giant cell (temporal) arteritis.","volume":"38","author":"Caselli","year":"1988","journal-title":"Neurology"},{"key":"R173-3-20210309","first-page":"199","article-title":"Tremor as an early manifestation of systemic lupus erythematosus.","volume":"12","author":"Venegoni","year":"1994","journal-title":"Clin Exp Rheumatol"},{"issue":"Pt 1","key":"R175-3-20210309","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/brain\/awf006","article-title":"Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients.","volume":"125","author":"Camdessanche","year":"2002","journal-title":"Brain"},{"key":"R176-3-20210309","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12035-012-8330-5","article-title":"alpha-synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration.","volume":"47","author":"Beyer","year":"2013","journal-title":"Mol Neurobiol"},{"key":"R177-3-20210309","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1096\/fj.12-206060","article-title":"T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy.","volume":"26","author":"Alessandri","year":"2012","journal-title":"FASEB J"},{"key":"R178-3-20210309","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fgene.2014.00382","article-title":"Phosphatases of alpha-synuclein, LRRK2, and tau: important players in the phosphorylation-dependent pathology of Parkinsonism.","volume":"5","author":"Taymans","year":"2014","journal-title":"Front Genet"},{"key":"R179-3-20210309","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.semarthrit.2013.10.007","article-title":"Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitors.","volume":"43","author":"Birnbaum","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"R180-3-20210309","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrneurol.2011.1","article-title":"Monoclonal antibody therapy-associated neurological disorders.","volume":"7","author":"Bosch","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"R181-3-20210309","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","article-title":"Guillain-Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy.","volume":"54","author":"Shin","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R182-3-20210309","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/BOR.0b013e32835b1366","article-title":"Biologics-induced autoimmune diseases.","volume":"25","author":"Perez-Alvarez","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"R183-3-20210309","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy.","volume":"37","author":"Stubgen","year":"2008","journal-title":"Muscle Nerve"},{"key":"R185-3-20210309","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/BOR.0000000000000116","article-title":"Inclusion body myositis: update.","volume":"26","author":"Lahouti","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R186-3-20210309","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A local antigen-driven humoral response is present in the inflammatory myopathies.","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J Immunol"},{"key":"R188-3-20210309","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.clineuro.2011.03.016","article-title":"The association of sporadic inclusion body myositis and Sjogrens syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype.","volume":"113","author":"Rojana-udomsart","year":"2011","journal-title":"Clin Neurol Neurosurg"},{"key":"R189-3-20210309","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/ene.12627","article-title":"High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study.","volume":"22","author":"Dobloug","year":"2015","journal-title":"Eur J Neurol"},{"key":"R190-3-20210309","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jneuroim.2012.04.007","article-title":"Frequency of autoantibodies and correlation with HLA-DRB1 genotype in sporadic inclusion body myositis (s-IBM): a population control study.","volume":"249","author":"Rojana-Udomsart","year":"2012","journal-title":"J Neuroimmunol"},{"key":"R191-3-20210309","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/rheumatology\/41.4.440","article-title":"Primary Sjogrens syndrome associated with inclusion body myositis.","volume":"41","author":"Kanellopoulos","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R192-3-20210309","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s10067-003-0715-4","article-title":"Inclusion body myositis in connective tissue disorders: case report and review of the literature.","volume":"22","author":"Derk","year":"2003","journal-title":"Clin Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:45:06Z","timestamp":1620960306000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201508010-00003"}},"subtitle":["A Case Series of 8 Patients and Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":179,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000971","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}